Get started
BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1

BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Bonds

BMY chart


Full chart

Key stats


Market capitalization
‪97.06 T‬ARS
Dividend yield (indicated)
3.76%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4,646.286ARS
Net income (FY)
‪6.49 T‬ARS
Revenue (FY)
‪36.38 T‬ARS
Shares float
‪2.03 B‬
Beta (1Y)
0.41

About Bristol-Myers Squibb Company


Sector
Health Technology
CEO
Christopher S. Boerner
Headquarters
Princeton
Website
bms.com
Employees (FY)
‪34.1 K‬
Founded
1933
ISIN
ARDEUT112877
FIGI
BBG000L7BMZ1
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Highest yielding bonds


BMY.GC
Bristol-Myers Squibb Company 6.875% 01-AUG-2097
C
BMY3685700
Celgene Corporation 5.7% 15-OCT-2040
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
BMY5754772
Bristol-Myers Squibb Company FRN 20-FEB-2026
C
BMY4275603
Celgene Corporation 5.0% 15-AUG-2045
US110122EC8
BRIST.MYERS 23/63
BMY5007349
Bristol-Myers Squibb Company 5.25% 15-AUG-2043
C
BMY4124214
Celgene Corporation 4.625% 15-MAY-2044
US110122EL8
BRIST.MYERS 24/64
C
BMY4597874
Celgene Corporation 4.55% 20-FEB-2048
US110122EB0
BRIST.MYERS 23/53

Explore more bonds 

Sparks


Curated watchlists where BMY is featured.

See all sparks